Skip to main content

Table 8 Univariate and multivariate analyses of prognostic factors for patients in the CTEPH PH medication group

From: Mixed venous oxygen tension is a crucial prognostic factor in pulmonary hypertension: a retrospective cohort study

Variable

Univariate

Multivariate model 1

Multivariate model 2

Multivariate model 3

HR (95% CIv)

P

HR (95% CIv)

P

HR (95% CIv)

P

HR (95% CIv)

P

Age (years)

0.99 (0.959–1.020)

0.427

0.99 (0.951–1.025)

0.479

0.99 (0.966–1.027)

0.701

0.99 (0.955–1.033)

0.730

RAP (mmHg)

1.13 (1.034–1.237)

0.008

1.00 (0.864–1.127)

0.958

  

0.99 (0.861–1.119)

0.889

mPAP (mmHg)

1.05 (1.013–1.085)

0.008

    

0.99 (0.923–1.054)

0.688

CI (L/min/m2)

0.59 (0.352–1.034)

0.064

1.26 (0.569–2.983)

0.575

    

PVR (W.U)

1.17 (1.081–1.264)

 < 0.001

    

1.06 (0.895–1.250)

0.499

PaO2 (mmHg)

0.95 (0.904–0.994)

0.025

      

PvO2 (mmHg)

0.74 (0.651–0.842)

 < 0.001

0.73 (0.625–1.367)

 < 0.001

  

0.77 (0.633–0.930)

0.006

PvO2 < 35 mmHg

4.83 (1.133–20.608)

0.008

  

4.26 (0.871–20.820)

0.047

  

RAP ≥ 8 mmHg

2.80 (1.226–6.418)

0.019

  

2.08 (0.786–5.490)

0.142

  

CI < 2.5 L/min/m2

2.11 (0.931–4.782)

0.067

  

0.88 (0.317–2.416)

0.798

  

SvO2 (mmHg)

0.87 (0.816–0.924)

 < 0.001

      

A-aDO2 (mmHg)

1.07 (1.025–1.111)

0.002

      

BNP (pg/mL)

1.00 (1.001–1.004)

0.002

      

6MWD (m)

0.99 (0.984–0.994)

 < 0.001

      

FVC, %pred. (%)

0.99 (0.971–1.004)

0.112

      

DLCO, %pred. (%)

0.99 (0.977–1.011)

0.492

      

WHO functional class I + II (vs. III + IV)

0.22 (0.053–0.968)

0.014

      
  1. Statistically significant, P < 0.05, are shown in bold
  2. A-aDO2 alveolar-arterial oxygen gradient, BNP brain natriuretic peptide, CI cardiac index, CIv confidence interval, CTEPH chronic thromboembolic pulmonary hypertension, DLCO, %pred. percent predicted carbon monoxide diffusing capacity, FVC, %pred. percent predicted forced vital capacity, HR hazard ratio, mPAP mean pulmonary arterial pressure, PaO2 arterial oxygen tension, PH pulmonary hypertension, PvO2 mixed venous oxygen tension, PVR pulmonary vascular resistance, RAP right arterial pressure, SvO2 mixed venous oxygen saturation, WHO World Health Organization, W.U Wood units, 6MWD 6-min walk distance
  3. Model 1: Multivariate analysis by ESC/ERS risk stratification and age
  4. Model 2: Multivariate analysis by ESC/ERS and French risk stratification in yellow and red zone, and age
  5. Model 3: Multivariate analysis adding age and PvO2 to variables that were significant in univariate analysis